← Back to Skills Marketplace

Curevac Nv

by hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0

cross-platform ✓ Security Clean

27

Downloads

0

Stars

0

Active Installs

1

Versions

Install in OpenClaw

/install curevac-nv

Description

德国图宾根mRNA技术先锋，专注肿瘤免疫和罕见病，曾开发新冠疫苗CVnCoV，拥有20年mRNA研究积累。

README (SKILL.md)

历史时间线

2000 Steve Pascolo和Ingmar Hoerr在德国图宾根创立
2014 首次进入人体临床试验（癌症mRNA疫苗）
2020 与GSK合作开发新冠疫苗CVnCoV
2021 CVnCoV三期临床数据显示有效率仅48%
2022 重组战略，聚焦肿瘤免疫和罕见病
2023 与Regeneron达成合作

商业模式

mRNA平台应用于肿瘤免疫（个性化癌症疫苗）、罕见遗传病（mRNA替代缺失蛋白）和传染病。新冠疫苗失败后战略转向，从传染病聚焦到肿瘤和罕见病。

护城河分析

20年mRNA基础研究积累。与BioNTech和Moderna相比，CureVac更专注于肿瘤和罕见病。图宾根大学的研究人才是持续优势。

关键数据

2023年收入约5,000万欧元
市值约10亿欧元
员工约800人
10+临床阶段项目

有趣事实

CureVac创始人Ingmar Hoerr博士在2000年首次证明mRNA可以注射入体内作为治疗手段——这比BioNTech和Moderna的mRNA疫苗早了整整20年。

Usage Guidance

This appears safe to install from a security perspective. Treat its business and biotech facts as informational and verify time-sensitive figures such as revenue, market cap, and pipeline status from current sources.

Capability Analysis

Type: OpenClaw Skill Name: curevac-nv Version: 1.0.0 The skill bundle contains purely informational content regarding CureVac, a German biotechnology company. The files (_meta.json and SKILL.md) consist of historical timelines, business analysis, and key facts without any executable code, network requests, or suspicious instructions that could lead to prompt injection or data exfiltration.

Capability Assessment

✓ Purpose & Capability

The content is coherent with the stated purpose: a brief Chinese-language company profile covering CureVac history, business model, moat, and key facts.

✓ Instruction Scope

The instructions only describe when the skill should be read and do not ask the agent to override user intent, run tools, access data, or take actions.

✓ Install Mechanism

There is no install specification and no code files; the provided artifact is a single SKILL.md document.

✓ Credentials

No binaries, environment variables, credentials, network access, or local file access are requested.

✓ Persistence & Privilege

No persistence, background execution, privileged access, account mutation, or sensitive data handling is evidenced.

How to Use

Make sure OpenClaw is installed (local or Docker)
Run the install command in chat: /install curevac-nv
After installation, invoke the skill by name or use /curevac-nv
Provide required inputs per the skill's parameter spec and get structured output

Version History

v1.0.0

- 首发版本，介绍CureVac公司及其发展历程 - 覆盖历史时间线、商业模式、护城河和关键运营数据 - 明确CureVac在mRNA领域的技术积累与行业定位 - 针对肿瘤免疫和罕见病赛道的最新战略转型 - 增加与BioNTech、Moderna异同和有趣历史事实

Metadata

Slug curevac-nv

Version 1.0.0

License MIT-0

All-time Installs 0

Active Installs 0

Total Versions 1

Frequently Asked Questions

What is Curevac Nv?

德国图宾根mRNA技术先锋，专注肿瘤免疫和罕见病，曾开发新冠疫苗CVnCoV，拥有20年mRNA研究积累。 It is an AI Agent Skill for Claude Code / OpenClaw, with 27 downloads so far.

How do I install Curevac Nv?

Run "/install curevac-nv" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Curevac Nv free?

Yes, Curevac Nv is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Curevac Nv support?

Curevac Nv is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Curevac Nv?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v1.0.0.

More Skills

💬 Comments